Posted in | News | Nanomaterials | Graphene

AGIN Receives SPE RESST KIPT Project Abstract for Study of Graphene in 3D Printing

American Graphite Technologies Inc. ("AGIN" or the "Company") and announces the receipt of the project abstract from Mr. D.V. Vynogradov (SPE RESST KIPT) project manager of the scientific team at the Kharkiv Institute of Physics & Technology ("KIPT") in Kharkiv, Ukraine.

The project, called P-600, will research the properties of nanocarbon contained matter (graphene) as working material for 3D printing. The project will be a partnership between AGIN, Science and Production Establishment "Renewable Energy Sources and Sustainable Technologies" ("RESST") National Science Center "KIPT" National Academy of Science of Ukraine and Institute of Solid State Physics and Material Science National Science Center "KIPT" National Academy of Science of Ukraine.

The scientific team will consist of 8 scientists (1 Prof., D.Sc, 2 PhD's; 3 former weapons scientists and 2 PhD student) including Mr. Vynogradov. The expertise of the team will include the fields of nanotechnology, 3D printing, solid state physics, physical materials and thermal physics.

In the abstract received by the Company, Mr. Vynogradov noted, "The perspective scope of research as we think are thin films and extremely small-scale objects with nano and micro-meter dimensions. Thus, we plan to pay special attention to the research with creating the graphene objects into nano and micro-meter typical size."

The Company is waiting for the final approval from the Ministry of Education and Science of Ukraine and Science and Technology Centre in Ukraine ("STCU") which is expected to be released within two weeks.

The 3-D printing market is anticipated to grow to $5.2 Billion by the year 2020. http://www.forbes.com/sites/tjmccue/2012/03/27/3d-printing-industry-will-reach-3-1-billion-worldwide-by-2016/

For more information visit the website at www.americangraphitetech.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.